Valacyclovir and Esomeprazole magnesium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 304 people who take Valacyclovir and Esomeprazole magnesium. Common interactions include chronic kidney disease among females, and febrile neutropenia among males.
The phase IV clinical study analyzes what interactions people who take Valacyclovir and Esomeprazole magnesium have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
304 people who take Valacyclovir and Esomeprazole magnesium together, and have interactions are studied.
What is Valacyclovir?
Valacyclovir has active ingredients of valacyclovir hydrochloride. It is used in genital herpes. Currently, eHealthMe is studying from 36,390 Valacyclovir users.
What is Esomeprazole magnesium?
Esomeprazole magnesium has active ingredients of esomeprazole magnesium. It is used in gastroesophageal reflux disease. Currently, eHealthMe is studying from 19,669 Esomeprazole magnesium users.
Number of Valacyclovir and Esomeprazole magnesium reports submitted per year:

Valacyclovir and Esomeprazole magnesium drug interactions by gender *:
Valacyclovir and Esomeprazole magnesium drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Valacyclovir and Esomeprazole magnesium?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Dr. Anthony Wong, "Esomeprazole and gynaecomastia in obese adults", WHO pharmaceuticals newsletter: 2019, No. 2, 2019 Jan .
Related studies
Drug side effects by duration, gender and age:
- Valacyclovir side effects (36,390 reports)
- Esomeprazole magnesium side effects (19,669 reports)
Common Valacyclovir drug interactions:
- Valacyclovir and Aspirin: 5,368 reports
- Valacyclovir and Revlimid: 5,186 reports
- Valacyclovir and Prednisone: 4,936 reports
- Valacyclovir and Pantoprazole: 4,833 reports
- Valacyclovir and Bactrim: 4,272 reports
- Valacyclovir and Gabapentin: 4,048 reports
- Valacyclovir and Ondansetron: 3,652 reports
- Valacyclovir and Vitamin d: 3,598 reports
- Valacyclovir and Allopurinol: 3,258 reports
- Valacyclovir and Amlodipine: 3,156 reports
Browse interactions between Valacyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Esomeprazole magnesium drug interactions:
- Esomeprazole magnesium and Prednisone: 3,219 reports
- Esomeprazole magnesium and Pantoprazole: 2,413 reports
- Esomeprazole magnesium and Methotrexate: 2,220 reports
- Esomeprazole magnesium and Aspirin: 2,182 reports
- Esomeprazole magnesium and Omeprazole: 1,958 reports
- Esomeprazole magnesium and Furosemide: 1,943 reports
- Esomeprazole magnesium and Metformin: 1,594 reports
- Esomeprazole magnesium and Humira: 1,590 reports
- Esomeprazole magnesium and Gabapentin: 1,444 reports
- Esomeprazole magnesium and Prevacid: 1,441 reports
Browse interactions between Esomeprazole magnesium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on valacyclovir hydrochloride and esomeprazole magnesium (the active ingredients of Valacyclovir and Esomeprazole magnesium, respectively), and Valacyclovir and Esomeprazole magnesium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Valacyclovir and Esomeprazole magnesium.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Euthyrox and Drug Intolerance - 3 seconds ago
- Acetylsalicylic Acid and Lidocaine And Prilocaine drug interaction - 4 seconds ago
- Gentak and Clobex drug interaction - 4 seconds ago
- Arzerra and Methotrexate drug interaction - 5 seconds ago
- Septra and Ards (Acute Respiratory Distress Syndrome) - 21 seconds ago
- Macrodantin and Pruritus Generalised - 23 seconds ago
- Cosentyx and Glossitis - 23 seconds ago
- Trulicity and Omacor drug interaction - 25 seconds ago
- Nimodipine and Digoxin drug interaction - 28 seconds ago
- Losartan and Panniculitis - 29 seconds ago